US Bancorp’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-266
| Closed | -$22K | – | 4193 |
|
|
2022
Q3 | $22K | Buy |
266
+171
| +180% | +$14.1K | ﹤0.01% | 2968 |
|
|
2022
Q2 | $7K | Sell |
95
-120
| -56% | -$8.84K | ﹤0.01% | 3456 |
|
|
2022
Q1 | $24K | Buy |
215
+31
| +17% | +$3.46K | ﹤0.01% | 2964 |
|
|
2021
Q4 | $18K | Buy |
184
+43
| +30% | +$4.21K | ﹤0.01% | 3148 |
|
|
2021
Q3 | $13K | Buy |
141
+63
| +81% | +$5.81K | ﹤0.01% | 3307 |
|
|
2021
Q2 | $12K | Buy |
78
+66
| +550% | +$10.2K | ﹤0.01% | 3324 |
|
|
2021
Q1 | $2K | Buy |
12
+2
| +20% | +$333 | ﹤0.01% | 3675 |
|
|
2020
Q4 | $2K | Hold |
10
| – | – | ﹤0.01% | 3547 |
|
|
2020
Q3 | $2K | Hold |
10
| – | – | ﹤0.01% | 3433 |
|
|
2020
Q2 | $3K | Sell |
10
-3
| -23% | -$900 | ﹤0.01% | 3357 |
|
|
2020
Q1 | $4K | Hold |
13
| – | – | ﹤0.01% | 3243 |
|
|
2019
Q4 | $4K | Hold |
13
| – | – | ﹤0.01% | 3280 |
|
|
2019
Q3 | $2K | Sell |
13
-269
| -95% | -$41.4K | ﹤0.01% | 3417 |
|
|
2019
Q2 | $25K | Buy |
282
+13
| +5% | +$1.15K | ﹤0.01% | 2797 |
|
|
2019
Q1 | $24K | Buy |
269
+222
| +472% | +$19.8K | ﹤0.01% | 2789 |
|
|
2018
Q4 | $7K | Buy |
+47
| New | +$7K | ﹤0.01% | 3125 |
|
|
2014
Q3 | – | Sell |
-47
| Closed | -$33K | – | 3539 |
|
|
2014
Q2 | $33K | Buy |
47
+1
| +2% | +$702 | ﹤0.01% | 2662 |
|
|
2014
Q1 | $21K | Sell |
46
-39
| -46% | -$17.8K | ﹤0.01% | 2823 |
|
|
2013
Q4 | $29K | Buy |
+85
| New | +$29K | ﹤0.01% | 2624 |
|